Joseph Tintelnot

10PUBLICATIONS

68CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)ChemotherapyMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 19, 2026

Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy - A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study Group.

|Oct 18, 2025

Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial.

Alexander Stein, Eray Goekkurt, Salah-Eddin Al-Batran

|May 13, 2025

Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer.

Joseph Tintelnot, Yang Xu, Till R Lesker

|Nov 11, 2024

Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy.

Joseph Tintelnot, Lisa Paschold, Eray Goekkurt

|Mar 13, 2024

Tumor Response Evaluation Using iRECIST: Feasibility and Reliability of Manual Versus Software-Assisted Assessments.

Inka Ristow, Lennart Well, Nis Jesper Wiese

|Nov 23, 2023

Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.

Hans-Joachim Schmoll, Julia Mann, Fabian Meinert

Pageof 2

Frequent Collaborators

Alexander Stein

Martin Schönlein

Cenap Güngör

Leonie Konczalla

Victor G Puelles

Kristoffer Riecken

Lena Amend

Jens T Siveke

Danmei Zhang

Stefan Boeck

Frequent Collaborators

Alexander Stein

Martin Schönlein

Cenap Güngör

Leonie Konczalla